Acquisition by Gregory Waller of 937 shares of Arcadia Biosciences subject to Rule 16b-3
| RKDA Stock | USD 5.01 0.06 1.18% |
About 62% of Arcadia Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Arcadia Biosciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with Arcadia Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Arcadia Biosciences stock news signals to limit their universe of possible portfolio assets.
Arcadia |
Filed transaction by Arcadia Biosciences Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Arcadia Biosciences Fundamental Analysis
We analyze Arcadia Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arcadia Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arcadia Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Arcadia Biosciences is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Arcadia Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arcadia Biosciences stock to make a market-neutral strategy. Peer analysis of Arcadia Biosciences could also be used in its relative valuation, which is a method of valuing Arcadia Biosciences by comparing valuation metrics with similar companies.
Peers
Arcadia Biosciences Related Equities
| SNAX | Stryve Foods | 7.14 | ||||
| BTOG | Bit Origin | 4.48 | ||||
| BTTR | Better Choice | 2.40 | ||||
| FITSF | Koios Beverage | 0.00 | ||||
| BRID | Bridgford Foods | 0.86 | ||||
| PLAG | Planet Green | 1.25 | ||||
| SENEA | Seneca Foods | 1.42 | ||||
| FAMI | Farmmi | 3.23 | ||||
| LSF | Laird Superfood | 6.41 |
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |